Connection

AMY SCHEFLER to Retinal Neoplasms

This is a "connection" page, showing publications AMY SCHEFLER has written about Retinal Neoplasms.
Connection Strength

4.510
  1. Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma. JAMA Ophthalmol. 2023 Dec 01; 141(12):1133-1138.
    View in: PubMed
    Score: 0.803
  2. Angiographic characteristics and treatment approach in patients undergoing intra-arterial chemotherapy for retinoblastoma. Graefes Arch Clin Exp Ophthalmol. 2024 Apr; 262(4):1321-1328.
    View in: PubMed
    Score: 0.803
  3. USE OF FEMORAL ARTERY ULTRASOUND DURING INTRAARTERIAL CHEMOTHERAPY FOR CHILDREN UNDER 10 KG WITH RETINOBLASTOMA. Retina. 2018 07; 38(7):1420-1426.
    View in: PubMed
    Score: 0.551
  4. Mushroom-shaped secondary vasoproliferative tumor. Ophthalmic Surg Lasers Imaging. 2012 Oct 04; 43 Online:e104-6.
    View in: PubMed
    Score: 0.370
  5. Retinoblastoma: what is new in 2007-2008. Curr Opin Ophthalmol. 2008 Nov; 19(6):526-34.
    View in: PubMed
    Score: 0.282
  6. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Ophthalmology. 2007 Jan; 114(1):162-9.
    View in: PubMed
    Score: 0.245
  7. Update on retinoblastoma. Retina. 2004 Dec; 24(6):828-48.
    View in: PubMed
    Score: 0.215
  8. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success. Ophthalmology. 2004 May; 111(5):984-91.
    View in: PubMed
    Score: 0.207
  9. PRIMARY CENTRAL NERVOUS SYSTEM AND VITREORETINAL LYMPHOMA MIMICKING VIRAL RETINITIS IN A YOUNG PATIENT. Retin Cases Brief Rep. 2023 Sep 01; 17(5):567-571.
    View in: PubMed
    Score: 0.197
  10. Risk of Extraocular Extension in Eyes With Retinoblastoma Receiving Intravitreous Chemotherapy. JAMA Ophthalmol. 2017 12 01; 135(12):1426-1429.
    View in: PubMed
    Score: 0.132
  11. Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors. Invest Ophthalmol Vis Sci. 2011 Jul 23; 52(8):5359-68.
    View in: PubMed
    Score: 0.085
  12. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Arch Ophthalmol. 2010 Dec; 128(12):1619-23.
    View in: PubMed
    Score: 0.082
  13. Ophthalmic vasculature alterations following systemic chemotherapy and periocular Carboplatin treatment of advanced retinoblastoma. J Pediatr Ophthalmol Strabismus. 2010 Sep 22; 47 Online:e1-5.
    View in: PubMed
    Score: 0.080
  14. Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma. Retina. 2010 Apr; 30(4 Suppl):S66-8.
    View in: PubMed
    Score: 0.078
  15. Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype. Invest Ophthalmol Vis Sci. 2010 May; 51(5):2671-7.
    View in: PubMed
    Score: 0.077
  16. Retinal vascular tumor and peripheral retinal vasculitis in the setting of systemic tuberculosis. Ophthalmic Surg Lasers Imaging. 2009 Jul-Aug; 40(4):409-12.
    View in: PubMed
    Score: 0.074
  17. Blood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatment. Invest Ophthalmol Vis Sci. 2009 Mar; 50(3):1020-4.
    View in: PubMed
    Score: 0.070
  18. Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology. 2007 Jul; 114(7):1378-83.
    View in: PubMed
    Score: 0.064
  19. Optic nerve tissue shrinkage during pathologic processing after enucleation for retinoblastoma. Arch Ophthalmol. 2003 Jan; 121(1):73-5.
    View in: PubMed
    Score: 0.047
  20. Rapid growth of retinoblastoma in a premature twin. Arch Ophthalmol. 2002 Sep; 120(9):1232-3.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.